N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide

N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide Basic information
Product Name:N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide
Synonyms:N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide;N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(3-methoxyphenoxy)propyl)piperazin-1-yl)acetamide;Ranolazine Impurity 11;Ranolazine Impurity H;m-Ranolazine;Meta Ranolazine Impurity;Meta-Ranolazine;m-RanolazineQ: What is m-Ranolazine Q: What is the CAS Number of m-Ranolazine
CAS:1393717-46-8
MF:C24H33N3O4
MW:427.54
EINECS:
Product Categories:
Mol File:1393717-46-8.mol
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide Structure
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide Chemical Properties
Boiling point 637.8±55.0 °C(Predicted)
density 1.174±0.06 g/cm3(Predicted)
solubility Chloroform (Slightly), Methanol (Slightly)
form Sticky Solid
pka14.05±0.20(Predicted)
color Off-White to Light Yellow
Safety Information
MSDS Information
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide Usage And Synthesis
Usesm-Ranolazine is an impurity of Ranolazine Ethyl Dimer is an impurity of Ranolazine (R122500), an anti-ischemic agent which modulates myocardial metabolism. Antianginal.
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide Preparation Products And Raw materials
N-(2,6-DiMethylphenyl)-4-(2-hydroxy-3-phenoxypropyl)-1-piperazineacetaMide 1-Piperazineethanol, a-[(2-methoxyphenoxy)methyl]- Ranolazine Impurity 13 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-hydroxyphenoxy)propyl]- Ranolazine Impurity 8 Guaiacol glycidyl ether Ranolazine Ranolazine Impurity 7 Ranolazine Bis(N-Oxide)

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.